title: Clinical Radioimmunotherapy and Systemic Targeted Radiopharmaceutical Therapy (STaRT) programs in a radiation oncology environment.
authors.affiliation: Department of Radiation Oncology/T28, The Cleveland Clinic, Cleveland, Ohio 44195, USA. macklir@ccf.org
authors.forename: Roger M
authors.initials: RM
authors.lastname: Macklis
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006405:Hematology / Q000458:organization & administration / Q000639:trends; D006801:Humans; D007400:Interprofessional Relations; D016393:Lymphoma, B-Cell / Q000276:immunology / Q000532:radiotherapy; D009683:Nuclear Medicine / Q000458:organization & administration / Q000639:trends; D010348:Patient Care Team; D018787:Radiation Oncology / Q000458:organization & administration / Q000639:trends*; D016499:Radioimmunotherapy / Q000639:trends*; D019275:Radiopharmaceuticals / Q000627:therapeutic use*
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D019275:Radiopharmaceuticals; C422802:ibritumomab tiuxetan; C119496:tositumomab I-131